MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;Intrifiban;N6-(AMinoiMinoMethyl)-N2-(3-Mercapto-1-oxopropyl)-L-lysylglycyl-L-.alpha.-aspartyl-L-tryptophyl-L-prolyl-L-cysteinaMide Cyclic (16)-Disulfide;3-Mercaptopropionyl-HoMoarg-Gly-Asp-Trp-Pro-Cys-NH2
Eptifibatide is a glycopeptide platelet aggregation inhibitor. Its core process involves solid-phase synthesis of the cyclic heptapeptide. Molecular formula: C50H76N14O18S; CAS No.: 138832-21-8.
Contraindicated in active internal bleeding or severe hypertension. Requires renal function adjustment for dosing. Store lyophilized powder at controlled room temperature (20°C–25°C) away from moisture.